External resources New England Journal of Medicine: CagriSema REDEFINE 1 Trial Results New England Journal of Medicine: Retatrutide Phase 2 Trial for Obesity PMC: Efficacy and Safety of Cagrilintide Systematic Review and Meta-Analysis PMC: Cagrilintide Lowers Bodyweight Through Brain Amylin Receptors In case I do not see you, good afternoon, good evening, and good night
A total of 195 participants (average [SD] age, 42.8 [11.9] years
All content is original work protected under copyright, and may not be re-published, duplicated, or rewritten for commercial use without permission.
STORAGE Store below 25C (Air Conditioning)
Taken together, the findings highlight the importance of long-term treatment planning and structured transition strategies to reduce relapse after GLP-1 therapy withdrawal
This course is delivered by Dr Angela Wright, a specialist doctor with decades of clinical experience in weight management, obesity, and diabetes